Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PNCA

This publication has 17 references indexed in Scilit:

• New functional activities for the p21 family of CDK inhibitors.
  Genes & Development, 1997
• Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumors
  International Journal of Cancer, 1996
• Inhibition of p53-Mediated Growth Arrest by Overexpression of Cyclin-Dependent Kinases
  Molecular and Cellular Biology, 1996
• Expression of p21^WAF1/^CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma
  International Journal of Cancer, 1995
• The molecular basis of ovarian cancer
  Cancer, 1995
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
  Cell, 1994
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
  Cell, 1993
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993
• Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
  JNCI Journal of the National Cancer Institute, 1993
• p53 gene mutations and protein accumulation in human ovarian cancer.
  Proceedings of the National Academy of Sciences, 1993